Dr. Andy Liu is a Biostatistician at Ametris, specializing in the design and analysis of clinical trials for the biotech and pharmaceutical sectors. He earned his PhD in Biostatistics from the University of Michigan. Dr. Liu is an expert in applying Bayesian inference and adaptive trial designs to optimize sample sizes and accelerate drug development. At Ametris, he ensures that digital health data is transformed into rigorous, defensible evidence that meets the standards of global health authorities.
